Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders - PubMed

Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders

S W Shirley et al. Urology. 1978 Mar.

Abstract

Intravesical dimethyl sulfoxide (DMSO) has been used in the treatment of 213 patients with various inflammatory conditions involving the lower genitourinary tract, including intractable interstitial cystitis, radiation cystitis, chronic prostatitis, and chronic female trigonitis. Significant symptomatic relief has been achieved in the majority of patients so treated, and no systemic or local toxicity has been noted. Some patients failed to respond entirely, and others relapsed after DMSO treatment periods of several months, ultimately coming to augmentation cystoplasty or urinary diversion. However, because of its simplicity and ease of administration, intravesical DMSO therapy is recommended in all noninfectious or non-neoplastic inflammatory conditions presenting initially with severe symptoms, or that have failed to respond to conventional therapy.

Similar articles

• [The use of dimethyl sulfoxide in the treatment of intractable urinary frequency].

  Okamura K, Mizunaga M, Arima S, Tokunaka S, Inada F, Takamura T, Yachiku S. Okamura K, et al. Hinyokika Kiyo. 1985 Apr;31(4):627-31. Hinyokika Kiyo. 1985. PMID: 4036738 Japanese.

• Further experience with intravesical dimethyl sulfoxide in the treatment of interstitial cystitis.

  Stewart BH, Shirley SW. Stewart BH, et al. J Urol. 1976 Jul;116(1):36-8. doi: 10.1016/s0022-5347(17)58662-0. J Urol. 1976. PMID: 933285

• Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitis.

  Fowler JE Jr. Fowler JE Jr. Urology. 1981 Jul;18(1):21-6. doi: 10.1016/0090-4295(81)90489-1. Urology. 1981. PMID: 7257033

• Intravesical 50% dimethyl sulfoxide (Rimso-50) in treatment of interstitial cystitis.

  Sant GR. Sant GR. Urology. 1987 Apr;29(4 Suppl):17-21. Urology. 1987. PMID: 3551281 Review. No abstract available.

• Dimethyl sulfoxide (DMSO) as intravesical therapy for interstitial cystitis/bladder pain syndrome: A review.

  Rawls WF, Cox L, Rovner ES. Rawls WF, et al. Neurourol Urodyn. 2017 Sep;36(7):1677-1684. doi: 10.1002/nau.23204. Epub 2017 Feb 21. Neurourol Urodyn. 2017. PMID: 28220525 Review.

Cited by

• Dimethyl sulfoxide induces heme oxygenase-1 expression via JNKs and Nrf2 pathways in human umbilical vein endothelial cells.

  Liang C, Xue Z, Cang J, Wang H, Li P. Liang C, et al. Mol Cell Biochem. 2011 Sep;355(1-2):109-15. doi: 10.1007/s11010-011-0844-z. Epub 2011 Apr 30. Mol Cell Biochem. 2011. PMID: 21533649

• Intravesical treatments of bladder pain syndrome/interstitial cystitis.

  Neuhaus J, Schwalenberg T. Neuhaus J, et al. Nat Rev Urol. 2012 Dec;9(12):707-20. doi: 10.1038/nrurol.2012.217. Epub 2012 Nov 27. Nat Rev Urol. 2012. PMID: 23183946 Review.

• Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells.

  Wang CC, Lin SY, Lai YH, Liu YJ, Hsu YL, Chen JJ. Wang CC, et al. PLoS One. 2012;7(4):e33772. doi: 10.1371/journal.pone.0033772. Epub 2012 Apr 17. PLoS One. 2012. PMID: 22529897 Free PMC article.

• Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome.

  Colaco MA, Evans RJ. Colaco MA, et al. Curr Urol Rep. 2013 Oct;14(5):442-7. doi: 10.1007/s11934-013-0369-y. Curr Urol Rep. 2013. PMID: 24101384 Review.

• Dimethyl sulfoxide inhibits phagocyte influx into infected pleural spaces and phagocyte locomotion in vitro.

  Antony VB, Sahn SA, Repine JE. Antony VB, et al. Inflammation. 1983 Dec;7(4):377-85. doi: 10.1007/BF00916302. Inflammation. 1983. PMID: 6654475

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database